Reply from Authors re: Adri C. Voogd, Rob H.A. Verhoeven. Treatment of the Primary Tumour in the Presence of Metastases: Lessons from Breast Cancer. Eur Urol 2016;69:797-9Reply from Authors re: Alfred I. Neugut, Edward P. Gelmann. Treatment of the Prostate in the Presence of Metastases: Lessons from Other Solid Tumors. Eur Urol 2016;69:795-6: The Time Is Ripe to Test the Hypothesis that Radical Prostatectomy Improves Survival in Men with Distant Metastatic Prostate Cancer.

Autor: Sooriakumaran P; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden., Graefen M; Martini Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Wiklund P; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden. Electronic address: peter.wiklund@karolinska.se.

Publikováno v: European urology [Eur Urol] 2016 May; Vol. 69 (5), pp. 800-1. Date of Electronic Publication: 2015 Aug 22.

The expanding role of hormones in cancer

Autor: Edward P Gelmann

Publikováno v: Endocrine Oncology, Vol 1, Iss 1, Pp E1-E2 (2023)

In launching a new journal that is endorsed by as austere a group as the Society for Endocrinology, one is tempted at first to cite the opening words of Dickens’ Tale of Two Cities. We live in an age of instantaneous communication and immediate dis

Externí odkaz: https://doaj.org/article/ac3785d2b1f14fe0ac007094245e46ac

Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy The following institutions participated in this study: Cancer and Leukemia Group B Statistical Office, Durham, NC (Stephen George, Ph.D., supported by CA33601); Dartmouth Medical School–Norris Cotton Cancer Center, Lebanon, NH (Marc Ernstoff, MD, supported by CA04326); Georgetown University Medical Center, Washington, DC (Edward P. Gelmann, M.D., supported by CA77597); Massachussetts General Hospital, Boston, MA (Michael L. Grossbard, M.D., supported by CA12449); Mount Sinai School of Medicine, New York, NY (Lewis Silverman, M.D., supported by CA04457); North Shore–Long Island Jewish Medical Center, Manhasset, NY (Daniel R. Budman, M.D., supported by CA35279); Rhode Island Hospital, Providence, RI (William Sikov, M.D., supported by CA08025); Roswell Park Cancer Institute, Buffalo, NY (Ellis Levine, M.D., supported by CA02599); SUNY Upst

Autor: Kornblith, Alice B., Herndon, James E., Weiss, Raymond B., Zhang, Chunfeng, Zuckerman, Enid L., Rosenberg, Sylvia, Mertz, Magriet, Payne, David, Massie, Mary Jane, Holland, James F., Wingate, Patti, Norton, Larry, Holland, Jimmie C.

Publikováno v: Cancer; 15 August 2003, Vol. 98 Issue: 4 p679-689, 11p

Supplementary Material from CRISPR/Cas9-Mediated Point Mutation in Nkx3.1 Prolongs Protein Half-Life and Reverses Effects Nkx3.1 Allelic Loss

Autor: Edward P. Gelmann, Michael M. Shen, Sarah K. Bergren, Hailan Zhang, Maho Shibata, Cai Bowen

Supplementary Tables 1-4: Table 1. Primers for PCR amplification for CRISPR/Cas9 mouse models. Table 2. ssODN oligos. Table 3. Primers for genotyping of mouse mutation. Table 4. Antibodies used for immunofluorescence staining. Supplemental Figures 1-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::096388bff4e63e7bbf4c91be2f8b5cad
https://doi.org/10.1158/0008-5472.22426435.v1

Supplementary Figure Legend and Reference from NKX3.1 Suppresses TMPRSS2–ERG Gene Rearrangement and Mediates Repair of Androgen Receptor–Induced DNA Damage

Autor: Edward P. Gelmann, Tian Zheng, Cai Bowen

Supplementary Figure Legend and Reference. Legend for Supplementary Figures S1-S7. Also includes Supplementary Reference.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41d5fd616c8de8b140c34640967a06ea
https://doi.org/10.1158/0008-5472.22405085